Pharma Company And Drug Testing Industry Claim Trump's Rescheduling Move Will 'Increase Marijuana Abuse'
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Pharma Company And Drug Testing Industry Claim Trump's Rescheduling Move Will 'Increase Marijuana Abuse'" is generating significant coverage in the Business category, with 7 articles from 4 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Marijuana Moment, MJBizDaily, Business of Cannabis and The Motley Fool. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 118d ago.
Quick answers
Why is "Pharma Company And Drug Testing Industry Claim Trump's Rescheduling Move Will 'I" trending?
Because 4 independent news sources published 7 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Federal Marijuana Rescheduling Hearing Wraps Up, With DEA Judge Laying Out Next Steps Marijuana Moment · 122d ago
- Cannabis industry encouraged as DEA marijuana rescheduling hearings conclude MJBizDaily · 122d ago
- DEA Rescheduling Hearing Closes as States' Own Witness Concedes Regulation Reduces Crime Business of Cannabis · 122d ago
- President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray The Motley Fool · 122d ago
- Marijuana Companies Shouldn't Be Allowed To Defend Rescheduling By Joining Lawsuit, Anti-Cannabis Groups Say Marijuana Moment · 122d ago
- What cannabis operators should do after the DEA rescheduling hearings MJBizDaily · 122d ago
- Pharma Company And Drug Testing Industry Claim Trump's Rescheduling Move Will 'Increase Marijuana Abuse' Marijuana Moment · 122d ago
Topics
Related trends
‘Fireballs’ Are Coming As Mars And Jupiter Converge In The Night Sky
Stargazers face an active week as planetary alignments and meteor showers fill November's night skies.
DEA And Marijuana Rescheduling Opponents File Final Briefs In Hearing Ahead Of Judge's Decision
Opposing sides file final briefs as a critical federal marijuana rescheduling hearing approaches a judge's decision.
Breakthrough: FDA Approves First Drug Offering a 'Functional Cure' For Chronic Hepatitis B
The US Food and Drug Administration and Health Canada have approved bepirovirsen, marketed as Hibsago, as the first functional cure for chronic hepatitis B.
Hims & Hers Surges On 'Surprising And Inevitable' Deal With Eli Lilly
Eli Lilly has struck a deal allowing Hims & Hers Health to sell its obesity drugs Zepbound and Foundayo directly on its platform.
Illinois Governor And US Senator Push For Federal Hemp THC Product Ban To Take Effect Without Further Delay
An Illinois governor and a US senator push for an immediate federal hemp THC product ban as local businesses react.
Revolution Medicines’ pancreatic cancer drug has stunning commercial debut
Revolution Medicines' pancreatic cancer drug Rasonque achieves an eye-popping commercial debut, shattering analyst estimates.